News
Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 K27M mutations, a rare brain cancer mainly affecting young people. The ...
Get the latest Chime Financial, Inc. (CHYM) stock news and headlines to help you in your trading and investing decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback